• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• Twitter
• Newsletter

Advertisement

Product › Details

clinical research

	Next higher product group	pharma services

Record changed: 2021-05-10

Advertisement

More documents for clinical research

• [1] BlueRock Therapeutics LP. (7/19/21). "Press Release: BlueRock Therapeutics Receives FDA Fast Track Designation for DA01 in the Treatment of Advanced Parkinson’s Disease". Cambridge, MA....
• [2] Polyphor Ltd.. (7/16/21). "Press Release: Polyphor Provides Update on the Future of the FORTRESS Study of Balixafortide and Announces Initial Restructuring Steps". Allschwil....
• [3] AiCuris Anti-infective Cures AG. (7/8/21). "Press Release: AiCuris Starts Its First Pivotal Clinical Phase 3 Trial with Pritelivir for the Treatment of Herpes Simplex Virus Infections in Immunocompromised Subjects". Wuppertal....
• [4] Polyphor Ltd.. (6/28/21). "Press Release: Polyphor Provides Update on the Phase III FORTRESS Study of Balixafortide in Patients with Advanced HER2 Negative Breast cancer". Allschwil....
• [5] Abivax S.A.. (6/23/21). "Press Release: Abivax Reports Excellent Phase 2a Clinical Safety and Efficacy Results with 50mg ABX464 in Rheumatoid Arthritis". Paris....
• [6] Corat Therapeutics GmbH. (6/22/21). "Press Release: CORAT Antibody COR-101 Binds and Inhibits all B.1.617 SARS-CoV-2 Variants, Including the Fast Proliferating “delta” Variant". Braunschweig....
• [7] CureVac N.V.. (6/16/21). "Press Release: CureVac Provides Update on Phase 2b/3 Trial of First-Generation COVID-19 Vaccine Candidate, CVnCoV". Tübingen & Boston, MA....
• [8] Argenx SE. (6/7/21). "Press Release: Argenx to Regain Global Rights to Cusatuzumab". Breda....
• [9] Corat Therapeutics GmbH. (6/3/21). "Press Release: Corat Therapeutics Secures Additional Funding for Phase II Clinical Evaluation of Its COVID-19 Treatment". Braunschweig....
• [10] Relief Therapeutics Holding AG. (4/19/21). "Press Release: Relief Comments on Certain Statements Made by NeuroRx, Inc. in the Amended Form S-4 Filing of Big Rock Partners Acquisition Corp.". Geneva....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.